149 related articles for article (PubMed ID: 10490486)
1. Ablation of a left-sided accessory pathway during atrial fibrillation facilitated by intravenous flecainide.
Ng GA; Rankin AC
J Interv Card Electrophysiol; 1999 Oct; 3(3):279-82. PubMed ID: 10490486
[No Abstract] [Full Text] [Related]
2. Adenosine challenge in the diagnosis of inapparent accessory pathways.
Taggar JS; Carey PA
N Z Med J; 2007 Dec; 120(1267):U2873. PubMed ID: 18157199
[No Abstract] [Full Text] [Related]
3. Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.
Hegde S; Kumar V
JAMA Intern Med; 2016 Mar; 176(3):386-8. PubMed ID: 26784121
[No Abstract] [Full Text] [Related]
4. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.
Bollmann A; Binias KH; Toepffer I; Molling J; Geller C; Klein HU
Am J Cardiol; 2002 Nov; 90(9):1011-4. PubMed ID: 12398975
[No Abstract] [Full Text] [Related]
5. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model.
Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L
Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990
[TBL] [Abstract][Full Text] [Related]
6. ST-segment elevation in a patient receiving flecainide.
Chung-Esaki H; Tabas J; Goldschlager N
Arch Intern Med; 2011 Jan; 171(1):11-3. PubMed ID: 21220653
[No Abstract] [Full Text] [Related]
7. Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation.
Matsuo S; Yamane T; Date T; Lellouche N; Tokutake K; Hioki M; Ito K; Narui R; Tanigawa S; Nakane T; Tokuda M; Yamashita S; Aramaki Y; Inada K; Shibayama K; Miyanaga S; Yoshida H; Miyazaki H; Abe K; Sugimoto K; Taniguchi I; Yoshimura M
Am Heart J; 2011 Jan; 161(1):188-96. PubMed ID: 21167353
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Wijffels MC; Dorland R; Allessie MA
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
[TBL] [Abstract][Full Text] [Related]
9. Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation.
Hindricks G; Kottkamp H; Chen X; Willems S; Breithardt G; Borggrefe M
Eur Heart J; 1995 Jul; 16(7):967-70. PubMed ID: 7498213
[TBL] [Abstract][Full Text] [Related]
10. Identical atrial activation patterns during spontaneous initiations of atrial fibrillation.
Altemose GT; Scott LR; Miller JM
J Cardiovasc Electrophysiol; 2000 Mar; 11(3):373. PubMed ID: 10749363
[No Abstract] [Full Text] [Related]
11. Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation.
Tessarolo Silva F; Pedreira GC; Medeiros SA; Bortolotto AL; Araujo Silva B; Hurrey M; Madhavapeddi P; Schuler C; Belardinelli L; Verrier RL
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):205-213. PubMed ID: 31749267
[TBL] [Abstract][Full Text] [Related]
12. Localization and radiofrequency catheter ablation of left-sided accessory pathways during atrial fibrillation. Feasibility and electrogram criteria for identification of appropriate target sites.
Hindricks G; Kottkamp H; Chen X; Willems S; Haverkamp W; Shenasa M; Breithardt G; Borggrefe M
J Am Coll Cardiol; 1995 Feb; 25(2):444-51. PubMed ID: 7829799
[TBL] [Abstract][Full Text] [Related]
13. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
[TBL] [Abstract][Full Text] [Related]
14. Three-month lower-dose flecainide after catheter ablation of atrial fibrillation.
Hayashi M; Miyauchi Y; Iwasaki YK; Yodogawa K; Tsuboi I; Uetake S; Hayashi H; Takahashi K; Shimizu W
Europace; 2014 Aug; 16(8):1160-7. PubMed ID: 24706088
[TBL] [Abstract][Full Text] [Related]
15. Increase in organization index predicts atrial fibrillation termination with flecainide post-ablation: spectral analysis of intracardiac electrograms.
Tuan J; Osman F; Jeilan M; Kundu S; Mantravadi R; Stafford PJ; Ng GA
Europace; 2010 Apr; 12(4):488-93. PubMed ID: 20022876
[TBL] [Abstract][Full Text] [Related]
16. Wide QRS Complexes in an Asymptomatic Elderly Man With Permanent Atrial Fibrillation.
Takasugi N; Kubota T; Okura H
Circulation; 2020 May; 141(20):1656-1661. PubMed ID: 32421417
[No Abstract] [Full Text] [Related]
17. Long-term antiarrhythmic drug treatment after atrial fibrillation ablation: does a too obstinate rhythm control strategy bring serious risk of proarrhythmia to ablated patients?
De Vecchis R
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):117-118. PubMed ID: 30398614
[No Abstract] [Full Text] [Related]
18. Who should (or should not) be considered for catheter ablation of atrial fibrillation?
Andrade JG; Macle L
Can J Cardiol; 2013 Oct; 29(10):1292-4. PubMed ID: 23830288
[TBL] [Abstract][Full Text] [Related]
19. Wide QRS Tachycardia in a Man With a Medical History of Atrial Fibrillation.
Bucklew EA; Reis SE; Kancharla K
JAMA Intern Med; 2019 Apr; 179(4):567-569. PubMed ID: 30776049
[No Abstract] [Full Text] [Related]
20. Can recent-onset atrial fibrillation be safely and successfully treated with self-administered antiarrhythmic drugs?
Wyse DG
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):132-3. PubMed ID: 16265454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
